Clinical Decision Support Systems Market Growing at CAGR 11% with Top Companies like CERNER CORPORATION, EPIC, IBM, MCKESSON CORPORATION, MEDITECH, PHILLIPS HEALTHCARE, and SIEMENS HEALTHCARE

The clinical decision support systems market is expected to grow at a CAGR of about 11% during the forecast period. Physicians, nurses, and other healthcare professionals use CDSS to perform diagnosis and to review the diagnosis as a means of improving the result. Data mining may be piloted to examine the medical history of patients in combination with appropriate clinical research. Such examination can help predict possible events, which can range from drug interactions to disease symptoms. Some physicians prefer to evade over-consulting their CDSS, relying instead on their professional skill to determine the best course of care.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/17179

Need for Reducing Human Errors
Determining accurate medication doses is a difficult and time-consuming process and especially critical for infants and children in emergency situations. Calculations involving intricate formulas are often difficult to memorize, and mathematical errors can still occur even when the formulas are accurately recalled. Varying dosing programs based on indication and pharmacokinetics represent additional opportunities for error. Clinical decision support systems can give physicians and nurses easy and quick access to drug-specific dosing calculators, full drug profiles with age, weight, disease and renal adjustment dosing, and much more. Accurate medication information and dosing calculators, easily accessible within the medical workflow, can provide a significant reduction in errors. Owing to these capabilities of the system, there will be a boost in the growth of the clinical decision support systems market. Other factors that will affect the growth of this market include rising demand to reduce healthcare expenditure, need for improvement in quality of care, rising chronic disease population, and more adoption rate in emerging economies.

Key Developments in the Market:
February 2018 u2013 The US Food and Drug Administration (FDA) announced marketing clearance for Viz.AI's Contact application, the first artificial intelligence-based clinical decision support (CDS) solution cleared for sale in the United States. Viz.AI Contact is designed to analyze computed tomography (CT) results.

Major Players:
CERNER CORPORATION, EPIC, IBM, MCKESSON CORPORATION, MEDITECH, PHILLIPS HEALTHCARE, and SIEMENS HEALTHCARE, AMONG OTHERS.

Request Discount on this repots @ https://marketprognosis.com/discount-request/17179

Lack of Trust in the System as CDSS is in its Initial Stages of Development
The most often recurring barriers to CDSS implementation included earlier experience of dysfunctional computer systems in health care, general resistance towards changes in practice, and time management issues. In a study conducted by Oxford University, all groups listed numerous examples of dysfunctional healthcare IT systems, and they were worried of consequences if CDSS is built on the existing imperfect systems. This lack of trust in the healthcare professionals will lead to them not including for CDSS in their practice. This will eventually lead to the slowdown of the growth of this market. Other factors that will influence the decline of this market include lack of skilled labor, and suggestions from CDSS for unnecessary diagnostic testing will hinder the market growth.

North America to Maintain Dominance
North America is the leading market in the world, followed by Europe. Asia-Pacific is the fastest developing region. The large market share of North America can be attributed to factors such as the rising demand for quality healthcare delivery, need to curb increasing healthcare expenditure, and implementation of favorable initiatives & regulations are driving the growth of the CDSS market in the United States.

Enquiry Before Buying @ https://marketprognosis.com/enquiry/17179

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.